ab52627 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab52627 は 24 報の論文で使用されています。

  • Peng C  et al. Norcantharidin Suppresses Colon Cancer Cell Epithelial-Mesenchymal Transition by Inhibiting the avß6-ERK-Ets1 Signaling Pathway. Sci Rep 6:20500 (2016). PubMed: 26846153
  • Chen X  et al. Suppression of HSP27 increases the anti-tumor effects of quercetin in human leukemia U937 cells. Mol Med Rep 13:689-96 (2016). WB ; Human . PubMed: 26648539
  • Xie F  et al. Vaccarin attenuates the human EA.hy926 endothelial cell oxidative stress injury through inhibition of Notch signaling. Int J Mol Med 35:135-42 (2015). WB . PubMed: 25352009
  • Riess JW  et al. GLI1, CTNNB1 and NOTCH1 protein expression in a thymic epithelial malignancy tissue microarray. Anticancer Res 35:669-76 (2015). PubMed: 25667444
  • Moutal A  et al. CRMP5 Controls Glioblastoma Cell Proliferation and Survival through Notch-Dependent Signaling. Cancer Res 75:3519-28 (2015). PubMed: 26122847
  • Redmond EM  et al. Perivascular delivery of Notch 1 siRNA inhibits injury-induced arterial remodeling. PLoS One 9:e84122 (2014). WB ; Mouse . PubMed: 24416200
  • Gonzalez ME  et al. EZH2 expands breast stem cells through activation of NOTCH1 signaling. Proc Natl Acad Sci U S A 111:3098-103 (2014). PubMed: 24516139
  • Bohn O  et al. Utility of LRF/Pokemon and NOTCH1 protein expression in the distinction between nodular lymphocyte-predominant Hodgkin lymphoma and classical Hodgkin lymphoma. Int J Surg Pathol 22:6-11 (2014). PubMed: 24326827
  • Sliwa T  et al. Hyperexpression of NOTCH-1 is found in immature acute myeloid leukemia. Int J Clin Exp Pathol 7:882-9 (2014). IHC-P ; Human . PubMed: 24695418
  • Qiu M  et al. FOXA1 promotes tumor cell proliferation through AR involving the Notch pathway in endometrial cancer. BMC Cancer 14:78 (2014). WB, IHC-P ; Human . PubMed: 24512546
  • Schwarzer R  et al. Notch pathway inhibition controls myeloma bone disease in the murine MOPC315.BM model. Blood Cancer J 4:e217 (2014). WB . PubMed: 24927406
  • Zhang X  et al. FADD regulates thymocyte development at the ß-selection checkpoint by modulating Notch signaling. Cell Death Dis 5:e1273 (2014). ICC/IF ; Mouse . PubMed: 24901044
  • Camps J  et al. Genetic amplification of the NOTCH modulator LNX2 upregulates the WNT/ß-catenin pathway in colorectal cancer. Cancer Res 73:2003-13 (2013). PubMed: 23319804
  • Benner EJ  et al. Protective astrogenesis from the SVZ niche after injury is controlled by Notch modulator Thbs4. Nature 497:369-73 (2013). PubMed: 23615612
  • Su Y  et al. PSMA specific single chain antibody-mediated targeted knockdown of Notch1 inhibits human prostate cancer cell proliferation and tumor growth. Cancer Lett 338:282-91 (2013). Human . PubMed: 23752065
  • Giannelli M  et al. Photoactivation of bone marrow mesenchymal stromal cells with diode laser: Effects and mechanisms of action. J Cell Physiol 228:172-81 (2013). Mouse . PubMed: 22628164
  • Suprynowicz FA  et al. Conditionally reprogrammed cells represent a stem-like state of adult epithelial cells. Proc Natl Acad Sci U S A 109:20035-40 (2012). WB ; Human . PubMed: 23169653
  • Sakamoto K  et al. Reduction of NOTCH1 expression pertains to maturation abnormalities of keratinocytes in squamous neoplasms. Lab Invest 92:688-702 (2012). WB, IHC-P ; Human . PubMed: 22330335
  • Bailey AR  et al. Aberrant T-lymphocyte development and function in mice overexpressing human soluble amyloid precursor protein-a: implications for autism. FASEB J 26:1040-51 (2012). PubMed: 22085641
  • Lim SO  et al. Notch1 binds and induces degradation of Snail in hepatocellular carcinoma. BMC Biol 9:83 (2011). ICC/IF ; Human . PubMed: 22128911
  • Ma J  et al. Mammalian target of rapamycin regulates murine and human cell differentiation through STAT3/p63/Jagged/Notch cascade. J Clin Invest 120:103-14 (2010). PubMed: 20038814
  • Hanlon L  et al. Notch1 functions as a tumor suppressor in a model of K-ras-induced pancreatic ductal adenocarcinoma. Cancer Res 70:4280-6 (2010). PubMed: 20484026
  • Wei P  et al. Evaluation of selective gamma-secretase inhibitor PF-03084014 for its antitumor efficacy and gastrointestinal safety to guide optimal clinical trial design. Mol Cancer Ther 9:1618-28 (2010). PubMed: 20530712
  • Firestein R  et al. CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity. Nature 455:547-51 (2008). Human . PubMed: 18794900